Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin Metabolism in Reconstructive Surgery
NCT02411292Phase 2Completed
- Sponsor
- University of Utah
- Start
- Mar 2015
- Primary completion
- Mar 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of enoxaparin in venous thromboembolism (VTE), sponsored by University of Utah. Started Mar 2015; status: completed.
02
Drugs
enoxaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT02411292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02411292.